Explore All Access
Check if your research matches the topics covered in Drug Target Insights?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Drug Target Insights : Impact Factor & More
eISSN: 1177-3928pISSN: 1177-3928
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Drug Target Insights (DTI) is an international, indexed, peer-reviewed, open access, online only journal, published once a year. It covers current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central. Less
Drug Target Insights Key Metrics
CiteScore 
4.3
SJR
Q2Clinical Biochemistry
SNIP
0.65
Drug Target Insights Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | ABOUTSCIENCE SRL |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 1500 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drug Target Insights ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drug Target Insights
Cytotoxic activity, selectivity, and clonogenicity of fruits and resins of Saudi medicinal plants against human liver adenocarcinoma.
- 22 Oct 2024
- Drug target insights
Levofloxacin induces erythrocyte contraction leading to red cell death.
- 7 Oct 2024
- Drug target insights
Enhancement of apoptosis in Caco-2, Hep-G2, and HT29 cancer cell lines following exposure to Toxoplasma gondii peptides.
- 30 Sep 2024
- Drug target insights
In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3',4',7,8-tetrahydroxy-3-methoxyflavone isolated from Pistacia chinensis.
- 18 Jun 2024
- Drug target insights
Molecular targets and therapeutic potential of baicalein: a review.
- 6 Jun 2024
- Drug target insights
RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients.
- 31 May 2024
- Drug target insights
Cytotoxic activity, selectivity, and clonogenicity of fruits and resins of Saudi medicinal plants against human liver adenocarcinoma.
- 22 Oct 2024
- Drug target insights
Levofloxacin induces erythrocyte contraction leading to red cell death.
- 7 Oct 2024
- Drug target insights
Enhancement of apoptosis in Caco-2, Hep-G2, and HT29 cancer cell lines following exposure to Toxoplasma gondii peptides.
- 30 Sep 2024
- Drug target insights
In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3',4',7,8-tetrahydroxy-3-methoxyflavone isolated from Pistacia chinensis.
- 18 Jun 2024
- Drug target insights
Molecular targets and therapeutic potential of baicalein: a review.
- 6 Jun 2024
- Drug target insights
RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients.
- 31 May 2024
- Drug target insights
Compare Similar Journals with Drug Target Insights
Select Journals to Compare with Drug Target Insights
Total journals - 8
You can select up to 3 Journals at a time
CPT: Pharmacometrics and Systems Pharmacology
Publisher: WILEY
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Medicine in Drug Discovery
Publisher: Elsevier
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Emerging Infectious Diseases
Publisher: CENTERS DISEASE CONTROL & PREVENTION
Briefings in Bioinformatics
Publisher: OXFORD UNIV PRESS
Open Forum Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
Journal of the Pediatric Infectious Diseases Society
Publisher: OXFORD UNIV PRESS
0 Journals Selected to compare with
Drug Target Insights
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Drug Target Insights
How long has Drug Target Insights been actively publishing? 
Drug Target Insights has been in operation since 2006 till date.
What is the publishing frequency of Drug Target Insights?
Drug Target Insights published with a Continuous publication frequency.
How many articles did Drug Target Insights publish last year?
In 2023, Drug Target Insights publsihed 18 articles.
What is the eISSN & pISSN for Drug Target Insights?
For Drug Target Insights, eISSN is 1177-3928 and pISSN is 1177-3928.
What is Citescore for Drug Target Insights?
Citescore for Drug Target Insights is 4.3.
What is SNIP score for Drug Target Insights?
SNIP score for Drug Target Insights is 0.65.
What is the SJR for Drug Target Insights?
SJR for Drug Target Insights is Q2.
Who is the publisher of Drug Target Insights?
ABOUTSCIENCE SRL is the publisher of Drug Target Insights.
